Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2021; 46(2): 270-273


Impact of influenza on hematological and serological markers

Imran Nazir, Muhammad Ajmal Farid, Rizwan Rasul Khan, Khalid Khalil, Jamal Al Ghamd, Amna Al Kalkami.




Abstract

Objective: To observe the frequency and association of hematological and serological markers in influenza patients.
Methodology: This single-centered retrospective descriptive study was done in Makkah, Saudi Arabia for a 26 months period. We included all admitted confirmed H1N1 patients of both genders using simple random technique. H1N1 was confirmed by a qualitative RT-PCR test through a nasopharyngeal swab. The complete data of patients were extracted from electronic medical records. Blood complete and serological tests detail was documented. Data were analyzed by SPSS version 23. Independent samples t test was applied to see the association of independent variables with influenza A and influenza B patients.
Results: Out of 170 patients, 107(62.9%) were influenza A and 63(37.0%) were influenza B. Anemia was observed almost same (31.8% vs 31.7%) in influenza A and B (p=0.994). Leukopenia was seen 43.9% (n=47) and 25.4% (n=16) in influenza A and B patients, respectively (p=0.891). Thrombocytopenia was documented in 20.6% (n=22) influenza A while 4.8% (n=3) in influenza B (p

Key words: Influenza A and B, anemia, leukopenia, thrombocytopenia.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.